These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 21962830)
1. Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. Van Hauwermeiren F; Vandenbroucke RE; Libert C Cytokine Growth Factor Rev; 2011; 22(5-6):311-9. PubMed ID: 21962830 [TBL] [Abstract][Full Text] [Related]
2. A humanized tumor necrosis factor receptor 1 (TNFR1)-specific antagonistic antibody for selective inhibition of tumor necrosis factor (TNF) action. Kontermann RE; Münkel S; Neumeyer J; Müller D; Branschädel M; Scheurich P; Pfizenmaier K J Immunother; 2008 Apr; 31(3):225-34. PubMed ID: 18317365 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and Pharmacodynamic Characterisation of an Anti-Mouse TNF Receptor 1 Domain Antibody Formatted for In Vivo Half-Life Extension. Goodall LJ; Ovecka M; Rycroft D; Friel SL; Sanderson A; Mistry P; Davies ML; Stoop AA PLoS One; 2015; 10(9):e0137065. PubMed ID: 26352810 [TBL] [Abstract][Full Text] [Related]
4. Creation of an improved mutant TNF with TNFR1-selectivity and antagonistic activity by phage display technology. Nomura T; Abe Y; Kamada H; Inoue M; Kawara T; Arita S; Furuya T; Minowa K; Yoshioka Y; Shibata H; Kayamuro H; Yamashita T; Nagano K; Yoshikawa T; Mukai Y; Nakagawa S; Tsunoda S; Tsutsumi Y Pharmazie; 2010 Feb; 65(2):93-6. PubMed ID: 20225650 [TBL] [Abstract][Full Text] [Related]
5. Japonicone A antagonizes the activity of TNF-α by directly targeting this cytokine and selectively disrupting its interaction with TNF receptor-1. Hu Z; Qin J; Zhang H; Wang D; Hua Y; Ding J; Shan L; Jin H; Zhang J; Zhang W Biochem Pharmacol; 2012 Dec; 84(11):1482-91. PubMed ID: 22981364 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor alpha (TNF-α), anti-TNF-α and demyelination revisited: an ongoing story. Caminero A; Comabella M; Montalban X J Neuroimmunol; 2011 May; 234(1-2):1-6. PubMed ID: 21474190 [TBL] [Abstract][Full Text] [Related]
9. Towards the next generation of anti-TNF drugs. Sfikakis PP; Tsokos GC Clin Immunol; 2011 Dec; 141(3):231-5. PubMed ID: 22004846 [TBL] [Abstract][Full Text] [Related]
10. Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2. Shibata H; Abe Y; Yoshioka Y; Nomura T; Sato M; Kayamuro H; Kawara T; Arita S; Furuya T; Nagano K; Yoshikawa T; Kamada H; Tsunoda S; Tsutsumi Y Cytokine; 2010 Apr; 50(1):75-83. PubMed ID: 20045350 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation. Kondo S; Sauder DN Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582 [TBL] [Abstract][Full Text] [Related]
12. The treatment of established murine collagen-induced arthritis with a TNFR1-selective antagonistic mutant TNF. Shibata H; Yoshioka Y; Abe Y; Ohkawa A; Nomura T; Minowa K; Mukai Y; Nakagawa S; Taniai M; Ohta T; Kamada H; Tsunoda S; Tsutsumi Y Biomaterials; 2009 Dec; 30(34):6638-47. PubMed ID: 19765818 [TBL] [Abstract][Full Text] [Related]
13. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway. Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474 [TBL] [Abstract][Full Text] [Related]
14. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions. Sfikakis PP Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1. Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the tumor necrosis factor-alpha pathway is radioprotective for the lung. Zhang M; Qian J; Xing X; Kong FM; Zhao L; Chen M; Lawrence TS Clin Cancer Res; 2008 Mar; 14(6):1868-76. PubMed ID: 18347190 [TBL] [Abstract][Full Text] [Related]